Effect of long-acting and short-acting calcium antagonists on cardiovascular outcomes in hypertensive patients
- 1 March 1997
- journal article
- Published by Elsevier in The Lancet
- Vol. 349 (9052) , 594-598
- https://doi.org/10.1016/s0140-6736(96)08359-6
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Final Outcome Results of the Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS)JAMA, 1996
- Risk of gastrointestinal haemorrhage with calcium antagonists in hypertensive persons over 67 years oldThe Lancet, 1996
- How safe are calcium antagonists in hypertension and coronary heart disease?Journal Of Hypertension, 1996
- Long‐Term Survival and Use of Antihypertensive Medications in Older PersonsJournal of the American Geriatrics Society, 1995
- The Risk of Myocardial Infarction Associated With Antihypertensive Drug TherapiesJAMA, 1995
- FDA Guidelines on TroughJournal of Cardiovascular Pharmacology, 1994
- The Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V)Archives of internal medicine (1960), 1993
- The 1988 Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood PressureArchives of internal medicine (1960), 1988
- Hypertension Control at the Work SiteJournal of Occupational and Environmental Medicine, 1976
- Detection and Treatment of Hypertension at the Work SiteNew England Journal of Medicine, 1975